• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Medical Researchers Analyze Social Media to Understand Side Effects of Pain Meds

by HITC Staff 11/19/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

 

FDA Unveils Draft of Social Media Guidance for Pharma Companies

Harnessing the power of social media, medical researchers have sifted through more than two billion tweets and online posts to study the harmful side effects of narcotics medication taken for chronic pain. The research team, led by the Cedars-Sinai Center for Outcomes Research and Education, reviewed a vast collection of patient entries on Twitter and social media forums such as askapatient.com and patientslikeme.com.

The unfiltered sentiments posted on these sites revealed details not often captured by physicians or traditional clinical research about the gastrointestinal side effects of narcotics medication. In online messages, for example, some patients described experiencing severe constipation that was even more debilitating than their underlying illnesses.

The researchers believe the study is the first of its kind to analyze social media data related to gastrointestinal side effects from narcotics.

“Social media can be used as a huge epidemiological database, a treasure-trove of insights from patients about their illness experiences, their treatments, and their attitudes and beliefs about health and disease,” said Brennan Spiegel, MD, MSHS, director of Cedars-Sinai Health Services Research and director of the Center for Outcomes Research and Education.

The study appears online in the Journal of Opioid Management. It was conducted in collaboration with Corey Arnold, PhD, from the UCLA Medical Imaging and Informatics Group, and funded by a grant from Takeda Pharmaceuticals International.

Investigators collected 2.5 million tweets and 217,000 posts from health-related social networking websites, using keywords such as “pain meds,” “bloating” and “nausea.” They also searched for the names of several pain-controlling narcotics, including hydrocodone, morphine and oxycodone.

To broaden their search, they turned to a social media data service called Treato, which collects and indexes patient and caregiver content from more than 3,000 health-related websites. Treato reviewed 1.8 billion posts in its repository. The investigators narrowed their search to 3,303 relevant tweets and posts that mentioned gastrointestinal side effects from narcotics medication.

“Social media provides the opportunity to make observations about patient populations outside of a clinical or research context,” Arnold said. “We were able to filter key signals from the noise in these massive datasets, allowing us to more efficiently distill important patient perspectives that can inform clinical care.” In the online messages, patients chronicled numerous gastrointestinal issues from narcotics, including nausea, vomiting and constipation, the most frequently cited issue.

The online data revealed that many people who use narcotics for pain relief often are not warned by their doctors of the potential side effects. Some patients turn to over-the-counter remedies or other solutions of questionable value without first consulting physicians.

The study had some limitations. Investigators were unable to determine whether any individual contributed data more than once by posting on multiple social media accounts. Also, because the demographics of the writers were unknown, it also was impossible to link the results to any specific group.

Still, the Cedars-Sinai and UCLA researchers said the rigor of sifting through social media allowed them to generalize their findings to a broader population and showed them how healthcare providers can improve patient care.

“These types of insights provide a blueprint for how to do better,” Spiegel said. “By informing doctors and prescribers about these results, we can hopefully improve the communication and shared decision-making between doctor and patient around pain medications.” 

Photo credit: Jason A. Howie via cc

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |